CLB

12.46 +0.24%
Core Laboratories Inc. NYSE Stock Oilfield Services Stocks
Open in Risen →

Core Laboratories Inc. (CLB) is listed on NYSE in the Mining sector. This page tracks real-time CLB price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.

Technical Analysis

RSI (14) 65.5 Near Overbought
Market Cap $571.7M
Volume 357.9K

Fundamentals — 10-Q Q2 2026

Revenue $246.4M
Net Income $5.2M
EPS $0.11
Gross Margin 17.4%
Operating Margin 4.5%
Net Margin 2.1%
Debt / Equity 0.4x
P/E Ratio 113.3x

Earnings

Recent Insider Trades

Name Title Type Shares Price Value Date
Bruno Lawrence Chairman and CEO Buy 5,000 $10.78 $53,900 2026 Jul 31
Sodderland Jan Willem Director Buy 600 $17.07 $10,242 2020 May 7
Goldman Sachs Group Inc 10% Owner Buy 676 $9.34 $6,313 2020 Apr 1
Bruno Lawrence President & COO Buy 3,000 $34.86 $104,580 2020 Feb 3
Elvig Mark F VP,Counsel & Secretary Sell 600 $37.93 $22,759 2020 Jan 2
Barnett Gregory Barry Director Buy 3,000 $38.67 $116,000 2019 Aug 14
Daniels Kevin CAO & Treasurer Sell 428 $66.25 $28,355 2019 Mar 11
Sodderland Jan Willem Director Buy 200 $85.76 $17,152 2018 Oct 29
Daniels Kevin CAO & Treasurer Sell 73 $112.63 $8,222 2018 Aug 14
Straughen Michael Director Buy 106 $118.65 $12,577 2017 Feb 1
Carnes Martha Z. Director Buy 200 $115.20 $23,040 2017 Jan 30
Sodderland Jan Willem Director Buy 300 $93.90 $28,170 2016 Feb 2
Sodderland Jan Willem Director Buy 300 $106.20 $31,860 2015 Jul 24
Kearney Michael C Director Sell 1,000 $128.52 $128,520 2015 May 12
van Kempen Margaret Ann Director Buy 250 $102.07 $25,518 2015 Feb 3
Sodderland Jan Willem Director Buy 300 $94.54 $28,362 2015 Feb 2
Elvig Mark F VP, Counsel & Secretary Sell 1,000 $138.03 $138,030 2014 Nov 17
van Geuns Lucia Director Buy 95 $143.98 $13,678 2014 Nov 14
Dunlap Charles L Director Buy 500 $147.59 $73,795 2014 Aug 4
Sodderland Jan Willem Director Buy 200 $147.89 $29,578 2014 Jul 30

Take CLB further

Set alerts on CLB

Get notified when Core Laboratories Inc. hits your price targets or technical conditions are met.

Get Started Free